Choi HJ,Jang HJ,Chung TW,et al.Catalpol suppresses advanced glycation end-products-induced inflammatory responses through inhibition of reactive oxygen species in human monocytic THP-1cells[J].Fitoterapia,2013,86(4):19-28.
[2]
van Sloten TT,Henry RM,Dekker JM,et al.Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2diabetes:the Hoorn study[J].Hypertension,2014,64(6):1 299-1 305.
[3]
Sena CM,Pereira AM,Seia R.Endothelial dysfunction-A major mediator of diabetic vascular disease[J].Biochim Biophys Acta,2013,1 832(12):2 216-2 231.
[4]
Donath MY,Dalmas,Sauter NS,et al.Inflammation in obesity and diabetes:islet dysfunction and therapeutic opportunity[J].Cell Metab,2013,17(6):860-872.
[5]
胡雪梅,皇甫健,刘洁,等.冬凌草甲素对脐静脉内皮细胞损伤的保护作用[J].中华糖尿病杂志,2014,6(10):753-757.Hu XM,HuangFu J,Liu J,et al.Protective effect of oridonin against the injuries in endothelial cells[J].Chinese Journal of Diabetes Mellitus,2014,6(10):753-757.
[6]
Versari D,Daghini E,Virdis A,et al.Endothelial dysfunction as a target for prevention of cardiovascular disease[J].Diabetes Care,2009,32(Suppl 2):S314-S321.
[7]
Schwarz V.Inflammation as a factor of the pathogenesis of insulin resistance and type 2diabetes[J].Ter Arkh,2009,81(10):74-80.
[8]
Kleemann R,Zadelaar S,Kooistra T.Cytokines and atherosclerosis a comprehend sive review of studies inmice[J].Cardiovase Res,2008,79(3):360-376.
[9]
Kampoli AM,Tousoulis D,Antoniades C,et al.Biomarkers of premature atherosclerosis[J].Trends Mol Med,2009,15(7):323-332.
